VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
59 hedge funds and large institutions have $31.3M invested in Viracta Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
76% less capital invested
Capital invested by funds: $132M → $31.3M (-$101M)
Holders
59
Holding in Top 10
–
Calls
$943K
Puts
$162K
Top Buyers
| 1 | +$4.92M | |
| 2 | +$2.02M | |
| 3 | +$835K | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$739K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$574K |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$10M | |
| 3 | -$4.16M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.72M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$2.02M |